title: Pharmacological characterization of uracil nucleotide-preferring P2Y receptors modulating intestinal motility: a study on mouse ileum.
abstract: We investigated the possible modulation of the intestinal contractility by uracil nucleotides (UTP and UDP), using as model the murine small intestine. Contractile activity of a mouse ileum longitudinal muscle was examined in vitro as changes in isometric tension. Transcripts encoding for uracil-sensitive receptors was investigated by RT-PCR. UDP induced muscular contractions, sensitive to PPADS, suramin, or MRS 2578, P2Y(6) receptor antagonist, and mimicked by PSB 0474, P2Y(6)-receptor agonist. UTP induced biphasic effects characterized by an early inhibition of the spontaneous contractile activity followed by muscular contraction. UTP excitatory effects were antagonized by PPADS, suramin, but not by MRS 2578, whilst the inhibitory effects were antagonized by PPADS but not by suramin or MRS 2578. UTPγS, P2Y(2)/(4) receptor agonist but not 2-thio-UTP, P2Y(2) receptor agonist, mimicked UTP effects. The inhibitory effects induced by UTP was abolished by ATP desensitization and increased by extracellular acidification. UDP or UTP responses were insensitive to TTX, atropine, or L-NAME antagonized by U-73122, inhibitor of phospholipase C (PLC) and preserved in the presence of nifedipine or low Ca(2+) solution. Transcripts encoding the uracil nucleotide-preferring receptors were expressed in mouse ileum. Functional postjunctional uracil-sensitive receptors are present in the longitudinal muscle of the mouse ileum. Activation of P2Y(6) receptors induces muscular contraction, whilst activation of P2Y(4) receptors leads to inhibition of the contractile activity. Indeed, the presence of atypical UTP-sensitive receptors leading to muscular contraction is suggested. All uracil-sensitive receptors are linked to the PLC pathway.
authors.affiliation: Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari (STEMBIO), Laboratorio di Fisiologia generale, Università di Palermo, Palermo, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Zizzo
authors.forename: Mariangela
authors.initials: M
authors.lastname: Mastropaolo
authors.forename: Jasmin
authors.initials: J
authors.lastname: Grählert
authors.forename: Flavia
authors.initials: F
authors.lastname: Mulè
authors.forename: Rosa
authors.initials: R
authors.lastname: Serio
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D007082:Ileum / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009924:Organ Culture Techniques; D018048:Receptors, Purinergic P2 / Q000502:physiology*; D014530:Uridine Diphosphate / Q000494:pharmacology* / Q000502:physiology; D014544:Uridine Triphosphate / Q000494:pharmacology* / Q000502:physiology
chemical_list: D018048:Receptors, Purinergic P2; C104749:purinoceptor P2Y4; C099845:purinoceptor P2Y6; D014530:Uridine Diphosphate; D014544:Uridine Triphosphate
references.citation: Neuropharmacology. 2006 May;50(6):690-704
references.pmid: 16434064
references.citation: Br J Pharmacol. 2000 Sep;131(1):51-6
references.pmid: 10960068
references.citation: Br J Pharmacol. 2009 Sep;158(1):243-51
references.pmid: 19466981
references.citation: Purinergic Signal. 2006 Nov;2(4):575-82
references.pmid: 18404459
references.citation: Br J Pharmacol. 2004 Nov;143(5):525-32
references.pmid: 15466449
references.citation: Eur J Pharmacol. 2003 Jan 5;458(3):305-11
references.pmid: 12504787
references.citation: Eur J Pharmacol. 2008 Oct 24;595(1-3):84-9
references.pmid: 18713670
references.citation: Auton Neurosci. 2006 Jun 30;126-127:299-306
references.pmid: 16616701
references.citation: Neuropharmacology. 2007 Aug;53(2):257-71
references.pmid: 17612577
references.citation: Purinergic Signal. 2008 Sep;4(3):213-36
references.pmid: 18604596
references.citation: Int Rev Cytol. 2004;240:31-304
references.pmid: 15548415
references.citation: Purinergic Signal. 2008 Sep;4(3):197-212
references.pmid: 18368521
references.citation: Lab Invest. 1998 Nov;78(11):1375-83
references.pmid: 9840612
references.citation: Pharmacol Ther. 2006 Jun;110(3):415-32
references.pmid: 16257449
references.citation: J Physiol. 2000 Apr 15;524 Pt 2:331-7
references.pmid: 10766915
references.citation: Life Sci. 2009 May 22;84(21-22):772-8
references.pmid: 19324061
references.citation: J Pharmacol Sci. 2011;115(3):293-308
references.pmid: 21350312
references.citation: Eur J Pharmacol. 1996 Dec 12;317(1):97-105
references.pmid: 8982725
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G923-30
references.pmid: 19164486
references.citation: Br J Pharmacol. 1995 Dec;116(7):2909-18
references.pmid: 8680724
references.citation: Pharmacol Rev. 2006 Sep;58(3):281-341
references.pmid: 16968944
references.citation: Pharmacol Rev. 1998 Sep;50(3):413-92
references.pmid: 9755289
references.citation: J Med Chem. 2006 Nov 30;49(24):7076-87
references.pmid: 17125260
references.citation: Br J Pharmacol. 1996 Jan;117(1):203-9
references.pmid: 8825364
references.citation: Gastroenterology. 2009 Apr;136(4):1349-58
references.pmid: 19250649
references.citation: Br J Pharmacol. 1994 Dec;113(4):1191-6
references.pmid: 7889272
references.citation: Neuropharmacology. 2002 Dec;43(8):1313-23
references.pmid: 12527481
references.citation: Basic Clin Pharmacol Toxicol. 2010 Jul;107(1):603-13
references.pmid: 20406212
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):299-309
references.pmid: 11111825
references.citation: Mol Pharmacol. 2009 Dec;76(6):1341-8
references.pmid: 19759354
references.citation: J Immunol. 2008 Feb 15;180(4):2659-68
references.pmid: 18250478
references.citation: Biochem Pharmacol. 2004 May 1;67(9):1763-70
references.pmid: 15081875
references.citation: Br J Pharmacol. 1998 May;124(1):5-12
references.pmid: 9630336
references.citation: Br J Pharmacol. 2003 Dec;140(7):1177-86
references.pmid: 14581177
references.citation: Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G401-10
references.pmid: 18063703
references.citation: Neurogastroenterol Motil. 2004 Feb;16(1):81-98
references.pmid: 14764208
references.citation: J Physiol. 2011 Feb 1;589(Pt 3):697-710
references.pmid: 21173079
references.citation: J Physiol. 2005 Apr 1;564(Pt 1):269-79
references.pmid: 15718265
references.citation: Am J Physiol Cell Physiol. 2000 Jul;279(1):C126-35
references.pmid: 10898724
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1998 Oct;358(4):464-73
references.pmid: 9826069
references.citation: J Clin Invest. 2003 Feb;111(3):371-9
references.pmid: 12569163
references.citation: Br J Pharmacol. 2011 Nov;164(6):1580-9
references.pmid: 21615720